(Q48794947)

15 February 2018

title

Expression of cyclooxygenase-2 and epidermal growth factor receptor in primary and recurrent glioblastoma multiforme. (English)

1 reference

15 February 2018

1 reference

9

1 reference

15 February 2018

author name string

Peter Sminia

1

1 reference

15 February 2018

T Rianne Stoter

2

1 reference

15 February 2018

Paul van der Valk

3

1 reference

15 February 2018

Paula H M Elkhuizen

4

1 reference

15 February 2018

Thea M Tadema

5

1 reference

15 February 2018

Gitta K Kuipers

6

1 reference

15 February 2018

W Peter Vandertop

7

1 reference

15 February 2018

M Vincent M Lafleur

8

1 reference

15 February 2018

publication date

20 October 2005

1 reference

15 February 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

15 February 2018

volume

131

1 reference

15 February 2018

issue

10

1 reference

15 February 2018

page(s)

653-661

1 reference

15 February 2018

https://scigraph.springernature.com/pub.10.1007/s00432-005-0020-5

exact match

0 references

cites work

EGFR overexpression and radiation response in glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS00432-005-0020-5

Current approaches to radiation therapy for malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-005-0020-5

The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-005-0020-5

Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: report from the Radiation Therapy Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-005-0020-5

Enhancing Radiotherapy With Cyclooxygenase-2 Enzyme Inhibitors: A Rational Advance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-005-0020-5

Growth stimulation and induction of epidermal growth factor receptor by overexpression of cyclooxygenases 1 and 2 in human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-005-0020-5

Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-005-0020-5

In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-005-0020-5

Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-005-0020-5

Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo

21 January 2018

1 reference

12 December 2020

Antisense targeting protein kinase A type I as a drug for integrated strategies of cancer therapy.

1 reference

12 December 2020

Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme

1 reference

12 December 2020

Molecular-genetic characterisation of gliomas that recur as same grade or higher grade tumours

1 reference

12 December 2020

Perils of immunohistochemistry: variability in staining specificity of commercially available COX-2 antibodies on human colon tissue

1 reference

12 December 2020

Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse

1 reference

12 December 2020

Radiation-induced cyclooxygenase 2 up-regulation is dependent on redox status in prostate cancer cells

1 reference

12 December 2020

Cyclooxygenase-2 in oligodendroglioma: possible prognostic significance

1 reference

12 December 2020

Cyclooxygenase-2: a therapeutic target

1 reference

12 December 2020

Cyclooxygenase in the treatment of glioma: its complex role in signal transduction

1 reference

12 December 2020

Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme

1 reference

12 December 2020

Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance

1 reference

12 December 2020

Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells

1 reference

12 December 2020

Radiation Therapy Oncology Group. Research Plan 2002-2006. Brain Tumor Committee

1 reference

12 December 2020

The role of cyclo-oxygenase 1 and 2 activity in prostaglandin E(2) secretion by cultured human adult microglia: implications for Alzheimer's disease

1 reference

12 December 2020

Significance of immunohistochemical expression of cyclooxygenase-2 in squamous cell carcinoma of the esophagus

1 reference

12 December 2020

Intracranial inhibition of glioma cell growth by cyclooxygenase-2 inhibitor celecoxib

1 reference

12 December 2020

Synergy between celecoxib and radiotherapy results from inhibition of cyclooxygenase-2-derived prostaglandin E2, a survival factor for tumor and associated vasculature

1 reference

12 December 2020

Endothelial COX-2 induction by hypoxia liberates 6-keto-PGF1 alpha, a potent epithelial secretagogue.

1 reference

12 December 2020

The role of cyclooxygenases in inflammation, cancer, and development

1 reference

12 December 2020

Microglia cyclooxygenase-2 activity in experimental gliomas: possible role in cerebral edema formation.

1 reference

12 December 2020

Cyclooxygenase-2 (COX-2) expression by immunohistochemistry in glioblastoma multiforme

1 reference

12 December 2020

Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis.

1 reference

12 December 2020

COX-2 inhibitors act as radiosensitizer in tumor treatment.

1 reference

12 December 2020

Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations

1 reference

12 December 2020

Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398.

1 reference

12 December 2020

Genetic sub-types of human malignant astrocytoma correlate with survival.

1 reference

12 December 2020

Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer

1 reference

12 December 2020

Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: a potential predictor of poor survival

1 reference

12 December 2020

Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma

1 reference

12 December 2020

Significance of Cox-2 expression in rectal cancers with or without preoperative radiotherapy

1 reference

12 December 2020

10.1007/S00432-005-0020-5

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018